Effect of Inhalation of Mint Oil on Vital Signs and O2 Saturation

Effect of Inhalation of Mint Oil on Vital Signs and O2 Saturation in neurosurgery Patient Hospitalized in Intensive Care Unit

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210131050189N1

Enrollment

Registered

2021-05-13

Start date

2021-05-16

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: neurosurgery Patient Hospitalized in Intensive Care Unit. Condition 2: neurosurgery Patient Hospitalized in Intensive Care Unit. Condition 3: neurosurgery Patient Hospitalized in Intensive Care Unit. Epidural hemorrhage Traumatic subdural hemorrhage Diffuse traumatic brain injury

Interventions

Intervention 1: Intervention group: 0.2 ml of 10% peppermint extract with 10 ml of distilled water will be nebulized through the nebulizer mask for 15 minutes with oxygen. Intervention 2: Control Gr

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age over 18 years and under 50 years No history of allergy to a particular substance- Awareness level above 13 according to Glasgow criteria No history of addiction No underlying disease (diabetes, high blood pressure, chronic heart failure, respiratory failure and kidney failure)- No endotracheal tube or 24 hours after extubation Stability of vital signs at least 12 hours before the extubation

Exclusion criteria

Exclusion criteria: Any sudden change in vital signs and general condition during the intervention that is a sign of intolerance to aromatherapy. Any change in the patient's breathing pattern during the intervention Change in the patient's medication during the intervention up to 6 hours after the intervention Complications after surgery such as severe pain, active bleeding, or infection

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: 6 hours after intervention. Method of measurement: blood pressure monitoring.;O2 Saturation. Timepoint: 6 hours after intervention. Method of measurement: pulse oximetry.;Pulse rate. Timepoint: 6 hours after intervention. Method of measurement: heart rate monitoring.;Respiratory rate. Timepoint: 6 hours after intervention. Method of measurement: respiratory rate monitoring.	—

Measure

Time frame

Blood pressure. Timepoint: 6 hours after intervention. Method of measurement: blood pressure monitoring.;O2 Saturation. Timepoint: 6 hours after intervention. Method of measurement: pulse oximetry.;Pulse rate. Timepoint: 6 hours after intervention. Method of measurement: heart rate monitoring.;Respiratory rate. Timepoint: 6 hours after intervention. Method of measurement: respiratory rate monitoring.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRaziyeh Ghafouri

Shahid Beheshti University of Medical Sciences

raziehghafouri@gmail.com+98 21 8820 2520

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026